ANS Girds As David To Medtronic's Goliath In Neuromodulation Market

Advanced Neurostimulation Systems will launch its line of internal pulse generators (IPGs) for the treatment of chronic pain in the U.S. later this year should FDA decide to downclassify the devices from Class III to Class II later this month, CEO Chris Chavez told investors at the First Union 2000 Brain and Spine Symposium in New York City Jan. 19.